Sixteen Years of Patient-Led Impact
Rooms that stayed open. Education people can use. A patient seat in work that used to happen without them.
2010 Incorporated Dec 3
2011 501(c)(3) · first rooms
2012 GATTEX approved · Gutsy Grant
2013 New York Times · CenterWatch
2015 10 NORD meetings
2016 Grant ends · rooms stay
2024 Logo revamp
2025 PIF-ECHO
2026 Site rebuild · Connect planned
SBSF does not prescribe, refer, or sell a therapy. Open a section for the public record.
ADVOCACY
Putting adult experience in the room
Advocacy at SBSF is putting adult lived experience into rooms that used to run on pediatric data, marketing copy, or silence. Patients lead. Clinicians keep medical authority.
Not advocacy: a logo on a therapy, a hospital ranking, or a promise that SBSF can change a coverage decision.
COMMUNITY
Official rooms and how they stay safe
Private Facebook spaces. New members answer entry questions and agree to the rules. Incomplete requests are declined with a note on how to fix them. Lived experience is welcome. Medical instructions are not.
Request Support Group Access →
10k+ is a public reach figure across rooms, site, and years — not a paid membership roll.
COMMUNITY
Education people actually use
The Educational Hub is one door and four pillars.
COMMUNITY
Gutsy Grant Award — history only
Estimated split of 48 awards
Funding ended in 2016. A future scholarship needs a new funder. There is no live apply button for a grant SBSF cannot pay.
INDUSTRY
Public record, 2011–2017
Andy served as Patient and Physician Communications Advisor while teduglutide (GATTEX) moved through NPS, NAIA, and Shire. FDA approved GATTEX in December 2012 for adults with SBS who need parenteral support. History — not a current retainer.
CenterWatch page → · GATTEX education →
Past public funders: NPS (later Shire / Takeda), Shire, Zealand Pharma, NAIA. Current listed supporter: Jablonski Physics Services. Unsigned conversations are not listed as sponsorships.
INDUSTRY
Partner versus sponsor
Not for sale: member lists, product posts inside private groups, preferred-pharmacy language, or a statement that SBSF recommends a drug, device, or hospital. No conference booths.
Corporate Sponsors → · Industry Partners → · For Clinicians →
CONTACT
Write the Foundation
Andrew E. Jablonski
Founder and Executive Director
Short Bowel Syndrome Foundation, Inc. · Lincoln, Nebraska
ajablonski@shortbowelfoundation.org
Contact form →